GMO U.S. Value ETF (NYSEARCA:GMOV) Short Interest Down 60.2% in July

GMO U.S. Value ETF (NYSEARCA:GMOVGet Free Report) was the target of a large drop in short interest during the month of July. As of July 15th, there was short interest totaling 3,493 shares, a drop of 60.2% from the June 30th total of 8,785 shares. Based on an average daily trading volume, of 34,885 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the company’s stock are short sold.

GMO U.S. Value ETF Stock Performance

NYSEARCA GMOV traded up $0.03 during trading on Wednesday, hitting $31.75. The stock had a trading volume of 1,783 shares, compared to its average volume of 16,811. GMO U.S. Value ETF has a 12 month low of $24.79 and a 12 month high of $31.79. The company’s 50-day moving average price is $30.37 and its two-hundred day moving average price is $29.33. The company has a market capitalization of $101.60 million, a PE ratio of 12.08 and a beta of 0.65.

Institutional Trading of GMO U.S. Value ETF

Institutional investors have recently made changes to their positions in the business. HighTower Advisors LLC grew its position in GMO U.S. Value ETF by 1.8% in the fourth quarter. HighTower Advisors LLC now owns 123,110 shares of the company’s stock valued at $3,384,000 after purchasing an additional 2,182 shares in the last quarter. Legacy Capital Wealth Partners LLC lifted its position in GMO U.S. Value ETF by 6.8% during the 4th quarter. Legacy Capital Wealth Partners LLC now owns 96,504 shares of the company’s stock worth $2,653,000 after buying an additional 6,156 shares in the last quarter. MML Investors Services LLC bought a new stake in GMO U.S. Value ETF during the 4th quarter worth about $1,794,000. Essential Partners LLC lifted its position in GMO U.S. Value ETF by 8.6% during the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after buying an additional 4,774 shares in the last quarter. Finally, StoneX Group Inc. acquired a new position in shares of GMO U.S. Value ETF during the 4th quarter worth about $1,536,000.

About GMO U.S. Value ETF

(Get Free Report)

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.

Featured Stories

Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.